The Department of Health and Human Services (HHS) says it has spent $290 million on a drug to treat radiation sickness in the event of a nuclear emergency. The HHS Administration for Strategic Preparedness and Response announced in a Tuesday release that it bought the drug Nplate from Amgen USA Inc.
https://aspr.hhs.gov/newsroom/Pages/ARS-Oct2022.aspx